Anna Kutschenko

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Transcranial direct current stimulation induces polarity-specific changes of cortical blood perfusion in the rat

Dorothee Wachter, Arne Wrede, Walter Schulz‐Schaeffer et al. · Experimental Neurology · 2010 · 131 citations

Life Sciences, Neurobiology, Neuroscience +10

In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA

Anna Kutschenko, Anja Manig, Marie‐Christine Reinert et al. · Neuroscience Letters · 2016 · 35 citations

Pharmacy, Pharmacology, Toxicology +9

Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1β and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells

E. Oetjen, R Blume, Irmgard Cierny et al. · Diabetologia · 2007 · 31 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +16

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study

S. Drexel, Martin Klietz, Katja Kollewe et al. · Journal of Neural Transmission · 2019 · 22 citations · Full text

Medicine, Neurology, Movement Disorders +15